Pfizer sues to block generic Viagra

Published



Pfizer Inc., the world’s biggest drug maker, sued to prevent Teva Pharmaceutical Industries Ltd. from selling a generic version of the Viagra impotence drug.

Teva, the world’s biggest maker of generic medicines, is seeking U.S. Food and Drug Administration approval to market a copy of the drug, whose chemical name is sildenafil citrate. New York-based Pfizer, in a complaint filed March 24, contends the copy would infringe a patent that expires in October 2019.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.